Fresh debate over PSA screening

Routine PSA screening can significantly reduce deaths from prostate cancer, fresh research suggests, but the RACGP remains unconvinced the evidence is strong enough.

Eleven-year follow-up of one of the major PSA trials shows the risk of dying from prostate cancer fell 21% in men offered regular PSA screening, compared with those not screened.

To prevent one prostate cancer death at 11 years follow-up, 1055 men would need to be invited for